Tag Archives: business planning

no menu

Howard Edelman

Howard Edelman is General Manager of Cothera LLC, a division of United Orthopedic Group, a global orthopedic company which provides medical devices and patient services into the secondary orthopedic market. Cothera was recently purchased by Breg in November of 2014.   Previously, Howard Edelman was the Founder and CEO of VitalWear, a profitable durable medical … Continue reading Howard Edelman


Robert Erwin

Mr. Erwin is president of iBio, Inc. (AMEX: IBIO), a biotechnology company commercializing a green plant platform for vaccines and therapeutic proteins, and he is chairman of Novici Biotech LLC (Vacaville, California). From 2003 until 2007 he was managing director of Bio-Strategic Directors LLC, a life science-industry consulting firm focused on intellectual property and strategy. … Continue reading Robert Erwin


Charles Gluchowski

Dr. Charles Gluchowski is currently the Managing Director of Life/Science Innovations LLC (LSI), a consulting firm that works on strategic and tactical fundraising, business development and R&D projects for life science companies.  Dr. Gluchowski has over 30 years of executive, business development and drug R&D experience in both established and start-up life science companies.  He … Continue reading Charles Gluchowski


Thomas J. Higgins

Thomas Higgins was the founding chief executive and is a director of Prosetta Corporation, a highly innovative biotechnology company focused on drug discovery and development, located in San Francisco, CA. He served as the president and CEO from 2003-2008. Prior to that, he was president and chief operating officer of Business for Social Responsibility. BSR … Continue reading Thomas J. Higgins


Andrei W. Konradi

Andrei W. Konradi is an expert in small molecule drug discovery. Andrei can assist life-sciences entrepreneurs in the following areas. Drug discovery feasibility assessment Strategies to create chemical intellectual property Definition of projects, milestones, and teams Utilizing contract research Andrei is an independent consultant serving several companies and nonprofit organizations. Formerly, Andrei was the leader … Continue reading Andrei W. Konradi


Ritu Lal

Dr. Ritu Lal is a leader in Pharmaceutical R and D. She has over 15 years of experience in Biotech/Pharma companies. Her passion is to bring healthcare products to patients in a cost-effective and efficient manner. In her role as a Senior Executive she has led Preclinical and Clinical Development teams in Biotech/Pharma companies. She … Continue reading Ritu Lal


Ted McCluskey

Ted McCluskey, MD/PhD was the 2011 President of Sand Hill Angels and has been on their Board of Directors for the past 5 years. In addition, he is currently a Clinical Consultant for Biotech, Diagnostic and Medical Device companies. At Stanford, he is an advisor in the SPARK drug development program and to the medical … Continue reading Ted McCluskey


Stephen Thau

Stephen Thau is a partner in Morrison & Foerster’s Palo Alto office and former co-chair of the firm’s Life Sciences Group. His practice focuses on the representation of life science, medical device, and other technology companies at all stages of their life cycles, from company formation, equity and debt financing, merger and acquisition transactions, to … Continue reading Stephen Thau